申请人:NeuroSearch A/S
公开号:US05200422A1
公开(公告)日:1993-04-06
A compound having the formula ##STR1## wherein R.sup.1 is hydrogen, NH.sub.2 or C.sub.1-6 -alkyl which may be branched; X is O, S, NCN; Y is O, S; R.sup.4, R.sup.5, R.sup.6 and R.sup.7 independently of each other are hydrogen, halogen, CF.sub.3, NO.sub.2, NH.sub.2, OH, C.sub.1-6 -alkoxy, C(.dbd.O)-phenyl or SO.sub.2 NR.sup.I R.sup.II wherein R.sup.I and R.sup.II independently are hydrogen or C.sub.1-6 -alkyl; R.sup.11 is hydrogen, halogen, NO.sub.2 or SO.sub.2 NR'R" wherein R' and R" independently are hydrogen or C.sub.1-6 -alkyl; R.sup.13 is hydrogen, halogen, phenyl, CF.sub.3, NO.sub.2 ; R.sup.12 is hydrogen or together with R.sup.13 forms a C.sub.4-7 -carbocyclic ring which may be aromatic or partially saturated; R.sup.14 is hydrogen or together with R.sup.13 forms a C.sub.4-7 -carbocyclic ring which may be aromatic or partially saturated; pharmaceutical compositions thereof, and a method of treating a disease in a mammal, including a human, responsive to opening of potassium channels, which comprises administering to a mammal in need thereof an effective amount of a compound as first above indicated, are disclosed.
本发明揭示了一种化合物,其化学式为##STR1##其中R.sup.1为氢,NH.sub.2或C.sub.1-6-烷基,可以是支链的;X为O,S,NCN;Y为O,S;R.sup.4,R.sup.5,R.sup.6和R.sup.7独立地为氢,卤素,CF.sub.3,NO.sub.2,NH.sub.2,OH,C.sub.1-6-烷氧基,C(.dbd.O)-苯基或SO.sub.2NR.sup.IR.sup.II,其中R.sup.I和R.sup.II独立地为氢或C.sub.1-6-烷基;R.sup.11为氢,卤素,NO.sub.2或SO.sub.2NR'R",其中R'和R"独立地为氢或C.sub.1-6-烷基;R.sup.13为氢,卤素,苯基,CF.sub.3,NO.sub.2;R.sup.12为氢或与R.sup.13共同形成一个C.sub.4-7-碳环,可以是芳香的或部分饱和的;R.sup.14为氢或与R.sup.13共同形成一个C.sub.4-7-碳环,可以是芳香的或部分饱和的;以及其制备的药物组合物和治疗响应于开放钾通道的哺乳动物,包括人类的方法,该方法包括向需要的哺乳动物中给予上述第一化合物的有效量。